PharmaNet/i3 names VP and general manager, neuroscience

Monday, July 16, 2012 11:05 AM

PharmaNet/i3, inVentiv Health’s clinical segment, has appointed Robert Lasser, M.D., MBA, vice president and general manager, neuroscience, overseeing the management of all clinical projects handled by PharmaNet/i3’s neuroscience group and the Rater Training Services team. Dr. Lasser will be based in Princeton, N.J.

Dr. Lasser, board-certified by the American Board of Psychiatry and Neurology, has more than 18 years of experience in medical practice and the pharmaceutical industry. He joins PharmaNet/i3 from Shire Pharmaceuticals, where he served as general manager for VYVANSE New Uses in multiple central nervous system (CNS) indications. Previously he served as Shire’s senior director in clinical development-medical affairs, overseeing clinical, medical and scientific input to the lifecycle for CNS therapeutics.

He also has held positions of increasing seniority at leading pharmaceutical companies where he directed global CNS medical strategy and clinical studies, and before that was in private practice and held several positions in adult and geriatric psychotherapy and psychopharmacology.

 

Share:          
CWWeekly

May 18

Research for All Act reaches Congress for second time seeking gender equality in basic research, clinical trials

MediciGlobal finds fewer trial dropouts among participants who actively pursue enrollment versus those recruited

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

May

Job satisfaction mixed as workload increases
Salaries not keeping pace with rise in work, responsibilities

Gamification moving from early science to patient use
Pharma looking to use games for early diagnosis, recruitment, adherence

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs